Literature DB >> 6407999

Inhibition of host cell catalase by Mycoplasma pneumoniae: a possible mechanism for cell injury.

M Almagor, S Yatziv, I Kahane.   

Abstract

This study demonstrates that viable Mycoplasma pneumoniae cells inhibit catalase activity in several types of intact human cells as well as in solution. Human erythrocyte catalase was inhibited up to 72%, and the inhibition of catalase in human cultured skin fibroblasts, lung carcinoma epithelial cells, and ciliated epithelial cells from human nasal polyps ranged between 75 and 80%. UV light-killed mycoplasmas failed to inhibit catalase activity both in intact cells and in vitro. After M. pneumoniae infection of human cultured skin fibroblasts, the level of malonyldialdehyde, an indicator for membrane lipid peroxidation, was 3.5 times higher than in control fibroblasts. Virulent M. pneumoniae completely inhibited catalase activity in solution, whereas the nonvirulent strains had a lesser ability to inhibit catalase activity. These findings suggest that as a result of host cell catalase inhibition by M. pneumoniae, the toxicity of the hydrogen peroxide generated by the microorganism and the affected cell is enhanced, thereby inducing host cell damage.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6407999      PMCID: PMC264771          DOI: 10.1128/iai.41.1.251-256.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  The interrelationship of virulence, cytadsorption, and peroxide formation in Mycoplasma pneumoniae.

Authors:  R P Lipman; W A Clyde
Journal:  Proc Soc Exp Biol Med       Date:  1969-09

2.  Cell attachment, growth characteristics and surface morphology of human upper-respiratory tract epithelium cultured on extracellular matrix.

Authors:  J M Wiesel; H Gamiel; I Vlodavsky; I Gay; H Ben-Bassat
Journal:  Eur J Clin Invest       Date:  1983-02       Impact factor: 4.686

3.  Ciliostatic, hemagglutinating, and proteolytic activities in a cell extract of Mycoplasma pneumoniae.

Authors:  D K Chandler; M F Barile
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

Review 4.  Mycoplasmas as agents of human disease.

Authors:  G H Cassell; B C Cole
Journal:  N Engl J Med       Date:  1981-01-08       Impact factor: 91.245

5.  Adsorption of Mycoplasma pneumoniae to neuraminic acid receptors of various cells and possible role in virulence.

Authors:  O Sobeslavsky; B Prescott; R M Chanock
Journal:  J Bacteriol       Date:  1968-09       Impact factor: 3.490

6.  Characterization of hemadsorption-negative mutants of Mycoplasma pneumoniae.

Authors:  E J Hansen; R M Wilson; W A Clyde; J B Baseman
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

7.  Long-term epidemiology of infections with Mycoplasma pneumoniae.

Authors:  H M Foy; G E Kenny; M K Cooney; I D Allan
Journal:  J Infect Dis       Date:  1979-06       Impact factor: 5.226

8.  Attachment of killed Mycoplasma gallisepticum cells and membranes to erythrocytes.

Authors:  M Banai; I Kahane; J Feldner; S Razin
Journal:  Infect Immun       Date:  1981-11       Impact factor: 3.441

9.  Attachment of mycoplasmas to erythrocytes: a model to study mycoplasma attachment to the epithelium of the host respiratory tract.

Authors:  I Kahane; S Pnini; M Banai; J B Baseman; G H Cassell; W Bredt
Journal:  Isr J Med Sci       Date:  1981-07

10.  Sialic acid residues mediate Mycoplasma pneumoniae attachment to human and sheep erythrocytes.

Authors:  J B Baseman; M Banai; I Kahane
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

View more
  13 in total

1.  The complete genomic sequence of Mycoplasma penetrans, an intracellular bacterial pathogen in humans.

Authors:  Yuko Sasaki; Jun Ishikawa; Atsushi Yamashita; Kenshiro Oshima; Tsuyoshi Kenri; Keiko Furuya; Chie Yoshino; Atsuko Horino; Tadayoshi Shiba; Tsuguo Sasaki; Masahira Hattori
Journal:  Nucleic Acids Res       Date:  2002-12-01       Impact factor: 16.971

2.  Complete sequence analysis of the genome of the bacterium Mycoplasma pneumoniae.

Authors:  R Himmelreich; H Hilbert; H Plagens; E Pirkl; B C Li; R Herrmann
Journal:  Nucleic Acids Res       Date:  1996-11-15       Impact factor: 16.971

3.  Parasitism of hamster trachea epithelial cells by Mycoplasma pneumoniae.

Authors:  Y Y Chen; D C Krause
Journal:  Infect Immun       Date:  1988-03       Impact factor: 3.441

4.  Protective effects of the glutathione redox cycle and vitamin E on cultured fibroblasts infected by Mycoplasma pneumoniae.

Authors:  M Almagor; I Kahane; C Gilon; S Yatziv
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

5.  Sequence analysis of 56 kb from the genome of the bacterium Mycoplasma pneumoniae comprising the dnaA region, the atp operon and a cluster of ribosomal protein genes.

Authors:  H Hilbert; R Himmelreich; H Plagens; R Herrmann
Journal:  Nucleic Acids Res       Date:  1996-02-15       Impact factor: 16.971

6.  Growth of mycoplasma transformed tTN129 cells depends on IGF-I.

Authors:  L T Van der Ven; L H Rademakers; A F Angulo; J C Giltay; I Wills; G H Jansen; I M Prinsen; A G Rombouts; P J Roholl; W Den Otter
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-07       Impact factor: 2.416

7.  Role of superoxide anion in host cell injury induced by mycoplasma pneumoniae infection. A study in normal and trisomy 21 cells.

Authors:  M Almagor; I Kahane; S Yatziv
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

8.  Human ciliated epithelial cells from nasal polyps as an experimental model for Mycoplasma pneumoniae infection.

Authors:  M Almagor; I Kahane; J M Wiesel; S Yatziv
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

9.  Interaction of Mycoplasma pneumoniae with HeLa cells.

Authors:  D C Krause; Y Y Chen
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

10.  Mycoplasma pneumoniae infection and environmental tobacco smoke inhibit lung glutathione adaptive responses and increase oxidative stress.

Authors:  Chirag Kariya; Hong Wei Chu; Jie Huang; Heather Leitner; Richard J Martin; Brian J Day
Journal:  Infect Immun       Date:  2008-07-21       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.